Loading organizations...
§ Venture Capital · New York City, NY, USA
Venture capital firm investing in early-stage disruptive growth companies in healthcare and technology.
Hambrecht Ducera Growth Ventures (HDGV) is a New York-based venture capital firm investing in early-stage disruptive growth companies, primarily in healthcare and technology, leveraging data science and disruption theory. The firm identifies high-potential startups through advanced analytics; its parent Ducera Partners has advised on over $850 billion in transactions since 2015. Key figures associated with the venture include Bill Hambrecht, founder of WR Hambrecht + Co, Mike Kramer from Ducera, and data scientist Thomas Thurston. HDGV's portfolio features companies like Tasso, in which it invested during a $100 million Series B round, and Proov, for which it led a $9.7 million Series A. Hambrecht Ducera Growth Ventures was launched in 2018 by Ducera Partners, building on the legacy of the WR Hambrecht + Co team.
Hambrecht Ducera Growth Ventures has 4 tracked investments across 4 companies. The latest tracked deal is $100.0M Series B in Tasso in December 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2021 | Tasso | $100.0M Series B | Anurag Kondapalli | Cedars Sinai, D. E. Shaw Group, Foresite Capital, InCube Ventures, J2 Ventures, Merck, Senvest Management, Silicon Valley Bank |
| Dec 1, 2021 | Proov | $10.0M Series A | Hambrecht Ducera Growth Ventures | Amicus Capital, Baroda Ventures, B Capital Group, BOW Capital, FIN Capital, Idealab, LGF, Resolute Ventures, SignalFire, Eddie LOU, Gokul Rajaram, Jason Goldberg, Manik Gupta, Robert Moore, Established Ventures, GingerBread Capital, Lightship Capital, Portfolia, SteelSky Ventures, WCC Partners |
| Aug 1, 2020 | Castor | $12.0M Series A | TWO Sigma Ventures | Humba Ventures, Index Ventures, INKEF Capital, Dharmesh Shah |
| Jan 14, 2020 | Buoy Health | $5.0M Series B Extension | Hambrecht Ducera Growth Ventures | TOM Richards, Carl Bradford Byers 🚑, Humana, Optum Ventures |